toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
Details
   print
  Records Links
Author (up) Gulati, A.M.; Hoff, M.; Salvesen, O.; Dhainaut, A.; Semb, A.G.; Kavanaugh, A.; Haugeberg, G. url  doi
  Title Bone mineral density in patients with psoriatic arthritis: data from the Nord-Trondelag Health Study 3 Type Journal Article
  Year 2017 Publication RMD Open Abbreviated Journal RMD Open  
  Volume 3 Issue 1 Pages e000413  
  Keywords Psoriatic arthritis; bone mineral density; osteoporosis  
  Abstract BACKGROUND: The risk of osteoporosis in patients with psoriatic arthritis (PsA) remains unclear. The aim of this study was to compare bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA) in patients with PsA and controls. PATIENTS AND METHODS: Patients with PsA and controls were recruited from the Nord-Trondelag Health Study (HUNT) 3. RESULTS: Patients with PsA (n=69) and controls (n=11 703) were comparable in terms of age (56.8 vs 55.3 years, p=0.32), gender distribution (females 65.2% vs 64.3%, p=0.87) and postmenopausal status (75.6% vs 62.8%, p=0.08). Body mass index (BMI) was higher in patients with PsA compared with controls (28.5 vs 27.2 kg/m(2), p=0.01). After adjusting for potential confounding factors (including BMI), BMD was higher in patients with PsA compared with controls at lumbar spine 1-4 (1.213 vs 1.147 g/cm(2), p=0.003) and femoral neck (0.960 vs 0.926 g/cm(2), p=0.02), but not at total hip (1.013 vs 0.982 g/cm(2), p=0.11). Controls had significantly higher odds of having osteopenia or osteoporosis based on measurements of BMD in both the femoral neck (p=0.001), total hip (p=0.033) and lumbar spine (p=0.033). CONCLUSION: Our population-based data showed comparable BMD in patients with PsA and controls. This supports that the PsA population is not at increased risk of osteoporosis.  
  Address Department of Rheumatology, Martina Hansens Hospital, Brum, Norway  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 2056-5933 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:28955483; PMCID:PMC5604602 Approved no  
  Call Number HUNT @ maria.stuifbergen @ Serial 1919  
Permanent link to this record
 

 
Author (up) Gulati, A.M.; Salvesen, O.; Thomsen, R.S.; Kavanaugh, A.; Semb, A.G.; Rollefstad, S.; Haugeberg, G.; Hoff, M. url  doi
  Title Change in cardiovascular risk factors in patients who develop psoriatic arthritis: longitudinal data from the Nord-Trondelag Health Study (HUNT) Type Journal Article
  Year 2018 Publication RMD Open Abbreviated Journal RMD Open  
  Volume 4 Issue 1 Pages e000630  
  Keywords cardiovascular disease; epidemiology; psoriatic arthritis  
  Abstract Objectives: The aim of this population-based study was to compare changes in cardiovascular (CV) risk factors over a decade-long period in patients who developed psoriatic arthritis (PsA) and the background population. Methods: Patients diagnosed with PsA (n=151) between 1998 and 2008 and matched controls (n=755) who participated in both the Nord-Trondelag Health Study (HUNT) 2 (1995-1997) and HUNT3 (2006-2008) were included. Mixed linear and logistic models were used to analyse the difference in mean change between HUNT2 and HUNT3 in patients and controls for body mass index (BMI), total cholesterol (TC), triglycerides, low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c) and blood pressure (BP). Results: At baseline (HUNT2), the patients who developed PsA compared with controls had higher BMI (27.2 vs 25.9 kg/m(2), p<0.001) and lower HDL-c (1.32 vs 1.40 mmol/L, p<0.03) and more were smokers (41.1 vs 28.5%, p<0.01). Seventy-eight per cent had skin psoriasis. The mean PsA disease duration at HUNT3 was 4.8 (+/-3.0) years. The patients who developed PsA gained less weight from HUNT2 to HUNT3 compared with the control group (2.1 vs 3.9 kg, difference in mean change -1.8 kg, 95% CI -3.9 to -0.5, p<0.01). TC, triglycerides, LDL-c or HDL-c values and BP declined in both groups, with no significant differences between groups. Conclusion: Longitudinal 10-year data did not show an increase in CV risk factors in patients who developed PsA compared with controls. This study implies that unfavourable CV risk factors in PsA were present before the diagnosis was established.  
  Address Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 2056-5933 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:29556420; PMCID:PMC5856915 Approved no  
  Call Number HUNT @ maria.stuifbergen @ Serial 2085  
Permanent link to this record
Select All    Deselect All
 |   | 
Details
   print

Save Citations:
Export Records: